Serologicals gets FDA license for UK facility

Serologicals Ltd. has received FDA license approval for its expanded monoclonal antibody production facility in Livingston, Scotland. The subsidiary of Serologicals Corp. ( is a world leader in the supply of blood typing reagents, and has been licensed by the FDA since 1989.

“The Livingston team continues to implement the highest quality standards in maintaining all regulatory requirements for both the United States and European markets,” says David A. Dodd, President and CEO of Serologicals.

The company’s products and technologies are used in a variety of applications within the areas of oncology, hematology, immunology, cardiology, and infectious diseases, as well as in the study of molecular biology.


Easily post a comment below using your Linkedin, Twitter, Google or Facebook account. Comments won't automatically be posted to your social media accounts unless you select to share.